Revolution Medicines

Revolution Medicines is a company specializing in precision oncology in the clinical stage, with a focus on creating new targeted treatments to hinder challenging targets in well-known growth and survival pathways, particularly the RAS and mTOR signaling pathways. The company's approach involves leveraging a deep understanding of genetic factors and adaptive resistance mechanisms in cancer, along with strong capabilities in drug discovery and medicinal chemistry, to develop a range of compounds that suppress crucial signaling points within the RAS and mTOR pathways.